Back to search

Boston University

Conditional prognostication of non-muscle invasive bladder cancer: a SEER-Medicare analysis

Abstract

dc:description.abstract

BACKGROUND: The risk of recurrence and progression is high among patients with non-muscle invasive bladder cancer (NMIBC). The challenge in disease management underlines the importance of accurate prognostic assessment. The risk profile of patients is expected to change at different follow-up times. Thereby, recurrence and progression rates during follow-up may differ from those estimated at diagnosis. Conditional survival, a prognostic measure that accounts for the time survived since diagnosis, provides a more accurate estimate than conventional survival estimated at time zero. OBJECTIVE: To assess the 6-, 12-, 24-, 36-, and 60-month conditional recurrence-free survival (RFS) and progression-free survival (PFS) after index transurethral resection of bladder tumor (TURBT). METHODS: The Surveillance, Epidemiology and End Results (SEER)-Medicare linked database was queried to identify patients aged ≥66-89 years diagnosed with Ta/Tis/T1 cN0 cM0 urothelial carcinoma of bladder (UCB) from 2000 to 2017. Conditional RFS and PFS estimates were estimated using the Kaplan-Meier method at pre-specified landmark times for the overall cohort and stratified by T stage and tumor grade. Univariable and multivariable Cox proportional hazards models were used to evaluate the associations of baseline characteristics with RFS and PFS at pre-specified landmark times. RESULTS: The 60-month conditional RFS and PFS at baseline were 0.39 and 0.93 respectively. Given a 6, 12, 24, 36, 48, 60 months event-free survivorship, the 60-month RFS were 0.52, 0.63, 0.73, 0.78, 0.82, and 0.85 respectively; PFS were 0.94, 0.95, 0.96, 0.97, 0.97, and 0.97 respectively. Conditional RFS and PFS rapidly improved within the first 24 months and then plateaued. When stratified by T stage, patients with T1 tumors had significantly shorter RFS and PFS (p<0.01); however, the most notable survival gain with additional years survived was observed in this subgroup. On multivariable analyses, T stage at diagnosis was less predictive of RFS and PFS with longer landmark times, while tumor grade and female gender remained significant independent predictors of RFS and PFS. CONCLUSION: The conditional survival analyses demonstrated improved survivorship with increased recurrence- and progression-free intervals. The risk of experiencing an event attenuated overtime with converging rates of survivorship across grade-stage subgroups. These data offer dynamic prognostication in directing more personalized care for patients with NMIBC.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chang, Chia-Chen
Advisors dc:contributor.advisor
  • Symes, Karen
  • Gershman, Boris

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/45767

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chang, Chia-Chen. Conditional prognostication of non-muscle invasive bladder cancer: a SEER-Medicare analysis. masters thesis, Boston University, 2022. https://hdl.handle.net/2144/45767